At the news
? NEUTRALIMPACT 4/10 CLUSTER filed Apr 16, 2026 at 20:00 ET
Twist Bioscience CEO Emily Leproust and CFO Adam Laponis sold a combined $345K in shares over the past week, with the majority of the activity coming from the CFO's $240K open-market sale. The CEO also exercised options and sold a portion of the underlying shares, indicating planned disposition rather than broad insider concern.
- CEO Emily Leproust sold 1,610 shares for $104,666 on 2026-04-21 as part of an option exercise and sale transaction.
- CFO Adam Laponis sold 4,000 shares for $240,000 on 2026-04-17 in an open-market transaction.
- Total open-market sales in the cluster amount to $344,666, representing approximately 0.009% of the company's $3.9B market cap.
- CEO also exercised derivative securities totaling 11,281 shares, with $85,298 in aggregate exercise cost, but no additional open-market sales beyond the 1,610 shares.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access